MetaVia Inc. — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2021-09-02

Reporting Person: KOVEN ANDREW I (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-02	Nonstatutory Stock Option (right to buy)	$4.52	A	60000	Acquired	2031-09-01	Common Stock (60000)	Direct

Footnotes

F1: Vests in 36 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the 36-month anniversary of the date of grant.